✦ LIBER ✦

A randomized phase III trial of gemcitabine+docetaxel+bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study

✍ Scribed by Hensley, M.L.; Miller, A.; O'Malley, D.M.; Mannel, R.S.; Behbakht, K.; Bakkum-Gamez, J.N.; Michael, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fixed-dose rate gemcitabine plus docetax

✍ Martee L. Hensley; John A. Blessing; Robert Mannel; Peter G. Rose 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Fixed-dose rate gemcitabine plus docetax

✍ Martee L. Hensley; John A. Blessing; Koen DeGeest; Ovadia Abulafia; Peter G. Ros 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Phase II trial of gemcitabine as second-

✍ Katherine Y Look; Alan Sandler; John A Blessing; Joseph A Lucci III; Peter G Ros 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Late-Breaking Abstract 1: Randomized pha

✍ D. Miller; V. Filiaci; G. Fleming; R. Mannel; D. Cohn; T. Matsumoto; K. Tewari; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A randomized phase III trial of paclitax

✍ R. Zon; Miller; M. Wang; J. Gralow; M. Dickler; M. Cobleigh; E. Perez; T. Shenki 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 129 KB

A Randomized Phase II Study of Paclitaxe

✍ Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nad 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 441 KB